MissionIR Articles

Amorfix Life Sciences is a theranostics company developing therapeutic products and diagnostic devices targeting misfolded protein diseases including ALS, cancer and Alzheimer’s Disease. The company offers two types of products: therapeutics, designed to target and…

RXi Pharmaceuticals is a biotech company focused on discovering, developing and commercializing innovative therapies based on its proprietary, next-generation RNAi platform. RXi’s first RNAi product candidate, RXI-109, entered into RXi’s first human clinical trial in…

ERBA Diagnostics is an emerging company in the global healthcare industry, operating in the core business segment of In Vitro Diagnostics (IVD). ERB’s product range includes a wide range of Clinical Chemistry Analyzers (Photometers &…

Viropro, through its subsidiaries, engages in the contract research, development, and manufacturing of biotherapeutic proteins for the treatment of various diseases. The company is also involved in the transfer of its proprietary technologies for industrial…

Addex Therapeutics focuses on the discovery and development of an emerging class of oral small molecule drugs that can be exquisitely selective for their intended target and confer significant therapeutic advantages over conventional “orthosteric” small…

Alliqua is a biomedical company focused on the development, manufacturing and marketing of its own proprietary products based on the company’s existing technology portfolio. ALQA currently markets its own proprietary brands of wound dressings: SilverSeal®…

Cyclacel Pharmaceuticals is a biopharmaceutical company developing oral therapies for the treatment of cancer and other serious diseases. The company has three product candidates are currently in clinical development: Sapacitabine (CYC682) for the treatment of…

MetaStat is a life science company operating through its subsidiary MetaStat BioMedical to develop and commercialize proprietary clinical diagnostic tests that predict the probability of blood borne systemic metastasis of cancer; and therapeutics to prevent…

ImmunoVaccine is a clinical-stage vaccine development company focused on advancing its patented DepoVax™ vaccine adjuvanting platform and product candidates for cancer therapy, infectious diseases and animal health. The company’s pipeline also includes a broad range…

Genmab is a biotech company engaged in the development of human antibody therapeutics for the treatment of cancer in Denmark and internationally. The company has one product on the market, ofatumumab, and is developing a…

Echo Therapeutics is a transdermal medical device company specializing in skin permeation technology. The company is developing its Prelude® SkinPrep System as a platform technology to allow for significantly enhanced and painless skin permeation that…

Ohr Pharmaceutical is engaged in the development of novel therapeutics for the treatment of serious and unmet medical needs. The company’s lead compounds include OHR/AVR 118 for the treatment of cancer cachexia, and Squalamine eye…

Cardium Therapeutics is a health sciences and regenerative medicine company focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses with the potential to address significant unmet medical needs.…

Sernova is a clinical-stage company developing products that provide a natural and immune-protected environment for delivering therapeutic cells to patients. The company is developing two novel closely integrated proprietary platform technologies: Cell Pouch System™ and…

Cipher Pharmaceuticals is a specialty pharmaceutical company that develops improved formulations of existing drugs using drug delivery technologies. The company has three products, all of which are approved by the FDA: Lipofen® for the treatment…